We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Root Extract from Traditional Chinese Medicinal Plant Shows Promise as Pain Reliever

By LabMedica International staff writers
Posted on 13 Jan 2014
Print article
Image: Corydalis yanhusuo plants and isolated rhizomes (inset) (Photo courtesy of Duoclieu, Vietnam).
Image: Corydalis yanhusuo plants and isolated rhizomes (inset) (Photo courtesy of Duoclieu, Vietnam).
A compound isolated from the roots of the traditional Chinese medicinal plant Corydalis yanhusuo has been found to be effective at relieving acute, inflammatory, and neuropathic pains.

Investigators at the University of California, Irvine (USA) and their collaborators at the Dalian Institute of Chemical Physics (China) isolated dehydrocorybulbine (DHCB) from the roots of C. yanhusuo, a flowering herbal plant that grows in Siberia, Northern China, and Japan. Extracts prepared from the roots of this plant have been used for many hundreds of years to alleviate menstrual cramps, chest pain, and abdominal pain.

The investigators tested DHCB in a rodent model. They reported in the January 2, 2014, online edition of the journal Current Biology that it displayed moderate dopamine receptor-antagonist activities. It was effective against inflammatory pain as well as injury-induced neuropathic pain and did not generate the sort of tolerance that develops with continued use of most conventional pain relievers, such as morphine.

Despite the promising results so far obtained, toxicity levels of purified DHCB remain to be established. While purified DHCB is not currently available, it is a component of the C. yanhusuo root or extracts that can be purchased in health stores or online.

“Today the pharmaceutical industry struggles to find new drugs. Yet for centuries people have used herbal remedies to address myriad health conditions, including pain. Our objective was to identify compounds in these herbal remedies that may help us discover new ways to treat health problems,” said senior author Dr. Olivier Civelli, professor of neuropharmacology at the University of California, Irvine. “We are excited that this one shows promise as an effective pharmaceutical. It also shows a different way to understand the pain mechanism.”

Related Links:

University of California, Irvine 
Dalian Institute of Chemical Physics


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: Molecular PCR-grade detection of Lyme bacteria right at the tick bite (Photo courtesy of En Carta Diagnostics)

Groundbreaking Molecular Diagnostic Kit to Provide Lyme Disease Detection in Minutes

Lyme disease, transmitted through tick bites, is a bacteria-caused illness that impacts 1.2 million individuals annually. The standard methods for diagnosing this disease include clinical examinations,... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more

Industry

view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more